The development of a precipitation flow injection immunoassay is descr
ibed, This approach is based on the immunoprecipitin reaction, whereby
the precipitate formed by binding bf the sample antigen (HIgG) to flu
orescein-labelled antibodies is retained on a filter built in on-line
in a flow-injection system, After dissolving the precipitate with sodi
um hydroxide solution the liberation of fluorescein-labelled antibodie
s results in a fluorescence signal that is directly proportional to th
e concentration of HIgG. The instrumental set-up is very simple and fu
lly automated, One assay cycle takes about 10 min, The RSD ranged betw
een 1 and 3%, depending on concentration, The detection limit was abou
t 140 fmol, The recovery from spiked serum samples was between 96 and
102%.